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ABSTRACT 
 
SLC45A2 encodes a putative transporter expressed primarily in pigment cells. 
SLC45A2 mutations cause oculocutaneous albinism type IV (OCA4) and 
polymorphisms are associated with pigmentation variation, but the localization, function, 
and regulation of SLC45A2 and its variants remain unknown. We show that SLC45A2 
localizes to a cohort of mature melanosomes that only partially overlaps with those 
expressing the chloride channel OCA2. SLC45A2 expressed ectopically in HeLa cells 
localizes to lysosomes and raises lysosomal pH, suggesting that in melanocytes, 
SLC45A2 expression, like OCA2 expression, results in the deacidification of maturing 
melanosomes to support melanin synthesis. Interestingly, OCA2 overexpression 
compensates for loss of SLC45A2 expression in pigmentation. Analyses of SLC45A2- 
and OCA2-deficient mouse melanocytes show that SLC45A2 likely functions later 
during melanosome maturation than OCA2. Moreover, the light skin-associated 
SLC45A2 allelic F374 variant restores only moderate pigmentation to SLC45A2-
deficient melanocytes due to rapid proteasome-dependent degradation resulting in 
lower protein expression levels in melanosomes than the dark skin-associated allelic 
variant. Our data suggest that SLC45A2 maintains melanosome neutralization initially 
orchestrated by transient OCA2 activity to support melanization at late stages of 
melanosome maturation, and that a common variant imparts reduced activity due to 
protein instability.   
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INTRODUCTION 
 
Melanins are the main source of pigmentation in the skin, hair, and eyes of mammals 
and other vertebrates. In humans, melanins serve as a barrier to the harmful effects of 
ultraviolet radiation and play an important role in the development and functioning of the 
retina (d'Ischia et al, 2015). Melanin synthesis takes place in skin and eye melanocytes 
and in ocular pigment epithelia within specialized organelles called melanosomes 
(Hearing, 2005; Marks & Seabra, 2001; Seiji et al, 1963). Heritable defects in melanin 
synthesis underlie the various forms of oculocutaneous albinism (OCA), characterized 
by impaired vision and increased susceptibility to skin and ocular cancers (Montoliu et 
al, 2014). To date, non-syndromic OCA has been linked to inactivating mutations in 
eight different genes (Montoliu et al., 2014; Pennamen et al, 2020). Sequence variation 
at the loci for some of these genes has been linked to variability in skin, hair and eye 
color among humans (Adhikari et al, 2019; Branicki et al, 2008; Crawford et al, 2017; 
Han et al, 2008; Lamason et al, 2005; Liu et al, 2015; Martin et al, 2017; Stokowski et 
al, 2007). Nevertheless, the molecular function of the majority of the OCA genes has not 
yet been fully characterized. 
 
OCA type 4 (OMIM #606574) represents 3-12% of total OCA patients in population 
studies (Gronskov et al, 2009; Lasseaux et al, 2018; Mauri et al, 2017; Wei et al, 2010; 
Wei et al, 2015) and is due to mutations in the SLC45A2 gene encoding the putative 
transmembrane transporter SLC45A2 (a.k.a. membrane associated transporter protein, 
MATP or antigen isolated from immuno-selected melanoma-1, AIM1)(Newton et al, 
2001). Mutations in the homologous gene underlie pigment dilution in a number of 
vertebrate species, including gorilla, several breeds of dog, tigers, horses, mice, shrew, 
chickens, pigeons, quail, frogs, fish and perhaps cattle (Caduff et al, 2017; DeLay et al, 
2018; Domyan et al, 2014; Dooley et al, 2013; Fukamachi et al, 2001; Gunnarsson et al, 
2007; Mariat et al, 2003; Minvielle et al, 2009; Newton et al., 2001; Prado-Martinez et al, 
2013; Rothammer et al, 2017; Tsetskhladze et al, 2012; Tsuboi et al, 2009; Wijesena & 
Schmutz, 2015; Winkler et al, 2014; Xu et al, 2013), and polymorphisms at the 
SLC45A2 locus are associated with skin tone differences and skin aging in several 
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human population studies (Adhikari et al., 2019; Branicki et al., 2008; Cerqueira et al, 
2014; Fracasso et al, 2017; Han et al., 2008; Jonnalagadda et al, 2016; Law et al, 2017; 
Liu et al., 2015; Lopez et al, 2014; Soejima & Koda, 2007; Stokowski et al., 2007; Yuasa 
et al, 2006). OCA4 patients have very low levels of pigmentation and phenotypically 
resemble OCA2 patients who lack the melanosomal chloride channel, OCA2 (Bellono et 
al, 2014), suggesting that SLC45A2 plays an important role in melanogenesis (Montoliu 
et al., 2014). Moreover, primary melanocytes from mice carrying the inactivating 
underwhite (uw) mutation of Slc45a2 (Du & Fisher, 2002; Newton et al., 2001) are 
severely hypopigmented (Costin et al, 2003), indicating a melanocyte-intrinsic defect; 
this would be consistent with the known restriction of SLC45A2 expression to pigment 
cells and a few other cell types (Baxter & Pavan, 2002; Bin et al, 2015; Harada et al, 
2001; Loftus et al, 2002). However, while the 12-transmembrane domain SLC45A2 
protein bears weak homology to sucrose transporters in plants and Drosophila 
(Lemoine, 2000; Meyer et al, 2011; Newton et al., 2001), its function in melanocytes is 
not understood.  
 
When expressed in yeast, mouse SLC45A2 functions at the plasma membrane as an 
acid-dependent importer of sugars (sucrose, glucose, or fructose) into the cytosol 
(Bartölke et al, 2014), suggesting that if SLC45A2 localized to acidic organelles it might 
facilitate export of a sugar and protons from the lumen to the cytosol. Neutralization of 
acidic early stage melanosomes is a critical process for melanogenesis (Bellono et al., 
2014; Raposo et al, 2001), as the key enzyme in melanogenesis, Tyrosinase, is 
minimally active at pH < 6 (Ancans et al, 2001; Halaban et al, 2002).  Consistent with a 
function in proton export and neutralization of acidic organelles, pigmentation of a 
zebrafish Slc45a2 mutant was rescued upon inhibition of endolysosomal and 
melanosomal acidification by treatment with bafilomycin A1 or by knockdown of the 
atp6v1 subunit of the vacuolar ATPase (Dooley et al., 2013), and knockdown of 
SLC45A2 in a pigmented melanoma cell line was reported to result in increased 
acidification of early stage melanosomes (Bin et al., 2015). However, despite limited 
evidence for SLC45A2 on melanosomes (Bin et al., 2015), the localization of SLC45A2 
within melanocytes has not yet been firmly established and it is not clear whether the 
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effects of SLC45A2 mutants reflect a direct effect of SLC45A2 function on the lumenal 
environment of melanosomes or an indirect effect due to impaired function of other 
organelles during melanosome maturation, as appears to be the case for the 
endolysosomal transporter MFSD12 (Crawford et al., 2017). Moreover, if SLC45A2 
indeed functions to neutralize melanosome pH, its function must be coordinated with 
that of OCA2, a major regulator of melanosomal pH (Bellono et al., 2014). While mice 
lacking expression of either SLC45A2 or OCA2 each have dramatic coat color dilution 
(Dickie, 1964; Sweet et al, 1998), mice with hypomorphic mutations in both Slc45a2 and 
Oca2 are more severely hypopigmented than either mutant alone (Lehman et al, 2000), 
suggesting that the encoded proteins have distinct functions.  
 
Differences in skin and hair pigmentation among European, Chinese, South American 
and South Asian human populations have been ascribed to a single genetic variant in 
SLC45A2 associated with the SNP rs16891982 (c.1122G>C). This results in a 
missense mutation p.Leu374Phe (ClinVar ID: 194990) and is correlated with lighter 
skin, hair, and eyes (Adhikari et al., 2019; Branicki et al., 2008; Cerqueira et al., 2014; 
Han et al., 2008; Jonnalagadda et al., 2016; Liu et al., 2015; Lopez et al., 2014; Soejima 
& Koda, 2007; Stokowski et al., 2007; Yuasa et al., 2006). The SLC45A2-F374 variant 
is nearly fixed in light-skinned human populations (Soejima & Koda, 2007). Residue 374 
lies within the 8th predicted transmembrane domain of SLC45A2 (Newton et al., 2001). 
When introduced into a homologous plant sucrose transporter, the amino acid 
corresponding to SLC45A2-F374 resulted in a 90% decrease in transporter activity 
without influencing the affinity for substrate (Reinders & Ward, 2015), and slc45a2 with 
an introduced F374 mutation was unable to rescue pigmentation in a slc45a2 mutant 
zebrafish (Tsetskhladze et al., 2012). However, the mechanism underlying the 
decreased activity of the SLC45A2-F374 variant is not understood. 
 
Analyses of SLC45A2 localization and function in pigment cells have been hindered by 
the lack of suitable specific antibodies. Here we assess the localization and function of 
SLC45A2 L374 and F374 variants in melanosome biogenesis by analyzing epitope-
tagged human SLC45A2 expressed in wild-type melanocytes, Slc45a2-deficient 
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melanocytes from underwhite mice, and HeLa cells, and by comparing the phenotypes 
of underwhite and OCA2-deficient pink-eyed dilute melanocytes. We show that 
expression of SLC45A2, like of OCA2, increases the pH of lysosomes and/or late 
endosomes when expressed ectopically in HeLa cells and that in melanocytes 
SLC45A2 localizes to melanosomes, where it likely neutralizes the melanosome lumen. 
We also show that OCA2 and SLC45A2 localize to distinct subsets of melanosomes 
and that the F374 variant accelerates SLC45A2 degradation but does not alter its 
localization. Our data indicate that melanosome neutralization is a critical process for 
the maintenance of eumelanin pigmentation that is regulated at more than one step 
during melanosome maturation. 
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RESULTS 
 
Functionality of HA-SLC45A2. Available antibodies to SLC45A2 were not suitable in 
our hands for immunolocalization analyses. Therefore, we used epitope-tagging to 
investigate SLC45A2 localization in melanocytes. Human SLC45A2 was tagged at the 
N- or C-terminus with either the HA11 epitope tag or EGFP and cloned into a retroviral 
vector. To determine whether the tagged transgenes were functional, they were 
expressed by recombinant retroviral infection in Slc45a2-deficient melan-uw cells from 
underwhite mice (Dickie, 1964). The Slc45a2uw allele encodes a non-functional 
truncated SLC45A2 protein and an undetectable transcript (Du & Fisher, 2002; Newton 
et al., 2001). Consequently, underwhite mice (Dickie, 1964; Lehman et al., 2000; Sweet 
et al., 1998) and primary melanocytes derived from them (Costin et al., 2003) are 
severely hypopigmented. Likewise, melan-uw cells are very pale compared to “wild-
type” (WT) immortalized melanocytes (melan-Ink4a) from C57BL/6-Ink4a-/- mice 
(Sviderskaya et al, 2002) (Figure 1a, b). While expression of the EGFP-tagged proteins 
failed to consistently restore pigmentation in melan-uw cells (data not shown), 
expression of the N-terminally HA-tagged human SLC45A2 (HA-SLC45A2) restored 
partial or full pigmentation in a substantial fraction of cells by 48-72 h post-infection, 
whereas pigmentation was not restored by expression of a similarly tagged unrelated 
polytopic protein - the putative sugar-nucleotide transporter, SLC35D3, which plays no 
role in pigmentation (Chintala et al, 2007) (Figure 1c-g). Additionally, quantitative 
analysis of melanin content in melan-uw cells stably expressing HA-SLC45A2 showed 
pigmentation at levels comparable to those of melan-Ink4a cells (see Figure 5f). These 
data indicate that HA-SLC45A2 is fully functional in melanocytes, and therefore validate 
its use in defining the localization and biosynthesis of SLC45A2. 
 
HA-SLC45A2 localizes to the limiting membrane of pigmented melanosomes and 
is partially enriched in a membrane subdomain.  To define SLC45A2 localization in 
melanocytes, HA-SLC45A2 was expressed either stably from recombinant retroviruses 
in melan-uw cells or by transient transfection in WT melan-Ink4a melanocytes. Cells 
were then fixed and processed for immunofluorescence microscopy with image 
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deconvolution (dIFM) using antibodies to the HA tag and to endogenous markers. In 
Slc45a2-deficient melan-uw cells, HA-SLC45A2 localized primarily to pigment granules 
(Figure 2a, b, d) often in a ring pattern around the granule (Figure 2b), in two to three 
puncta associated with the granule exterior (Figure 2a), or both (Figure 2c). The 
distinct patterns did not correlate with SLC45A2 expression levels. The melanosomes 
labeled by HA-SLC45A2 overlapped with those harboring the melanosomal enzymes 
Tyrosinase (TYR) and Tyrosinase-related protein-1 (TYRP1) (Figure 2a, b, d; overlap 
was  82.7 ± 1.3% with TYR and 79.2 ± 2.5% with TYRP1). By contrast, HA-SLC45A2-
labeled structures overlapped poorly with LAMP2, a membrane protein of lysosomes 
but not melanosomes, which are distinct organelles in eumelanin-generating 
melanocytes (Raposo et al., 2001) (Figure 2c, d; overlap was 34.4% ± 2.9% with 
LAMP2). Essentially identical results were observed for HA-SLC45A2 transiently 
expressed in melan-Ink4a cells (Figure EV1), which express endogenous SLC45A2. 
The degree of HA-SLC45A2 labeling on punctate subdomains vs. the melanosome 
limiting membrane was similar in transiently transduced melan-Ink4a and stably 
transduced melan-uw cells. Together, these data indicate that SLC45A2 localizes to 
mature melanosomes, where it is often enriched in subdomains associated with the 
limiting membrane. 
 
SLC45A2 localizes to lysosomes and regulates lysosomal pH when ectopically 
expressed in HeLa cells. When expressed in non-melanocytic cells, many 
melanosomal proteins localize to late endosomes and lysosomes (Ambrosio et al, 2016; 
Bellono et al, 2016; Berson et al, 2001; Bouchard et al, 1989; Calvo et al, 1999; 
Piccirillo et al, 2006; Simmen et al, 1999; Sitaram et al, 2009; Vijayasaradhi et al, 1995). 
Indeed, when expressed in HeLa cells and analyzed by dIFM, HA-SLC45A2 was 
detected on LAMP1-containing lysosomes – interestingly, in distinct punctate 
microdomains associated with the limiting membrane (Figure 3a), similar to the 
distribution in some melanosomes in melanocytes. This indicates that SLC45A2 
localizes to lysosomes when expressed ectopically in HeLa cells and retains its ability to 
accumulate in a membrane subdomain. 
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SLC45A2 was predicted to be a transmembrane transporter that influences 
melanosome pH (Bin et al., 2015; Newton et al., 2001). We have been unable to directly 
assess melanosomal pH in melanocytes using common cellular probes for lysosomal 
pH such as Lysotracker and Lysosensor because in our hands melanocytes fail to 
accumulate these probes intracellularly. However, we previously showed that the OCA2 
chloride channel expressed in HeLa cells localizes to lysosomes and neutralizes their 
lumenal pH, paralleling its role in neutralizing the lumenal pH of melanosomes to 
enhance TYR activity and melanogenesis in melanocytes (Bellono et al., 2014). We 
therefore tested whether SLC45A2 expression affects lysosomal acidification in HeLa 
cells using the pH-sensitive ratiometric dye Lysosensor DND-160. HeLa cells were 
transfected with either LAMP1-mCherry alone as a negative control, mCherry-OCA2 as 
a positive control, or LAMP1-mCherry and HA-SLC45A2 together to identify HA-
SLC45A2-expressing cells by live imaging (cotransfection efficiency measured by 
immunostaining was >90%). Cells preincubated with Lysosensor DND-160 were imaged 
at two emission wavelengths, and an average emission ratio was calculated for 
individual mCherry-LAMP1-positive compartments (see Materials and Methods). The 
corresponding pH for the average emission ratio was determined using a pH curve 
generated in each experiment by incubation in buffers with different pH values. Our 
results show that the average pH of lysosomes containing HA-SLC45A2 was nearly one 
pH unit higher than the pH of control cells and similar to the pH of mCherry-OCA2-
containing lysosomes (Figure 3b). These data indicate that, like OCA2, SLC45A2 can 
function to raise organellar pH, and suggest that in melanocytes SLC45A2 functions 
physiologically to raise melanosomal pH. 
 
SLC45A2 and OCA2 function at distinct stages of melanosome maturation. The 
similar function of SLC45A2 and OCA2 in neutralizing organellar pH led us to ask 
whether these transporters function at the same or distinct stages of melanosome 
maturation. We first used dIFM to compare the distribution of HA-SLC45A2 and HA-
OCA2 to melanosomes labeled by the mature melanosome marker TYRP1 in 
transiently transfected melan-Ink4a cells. HA-SLC45A2 and TYRP1 were largely 
present in the same compartments (86.58 ± 1.25% of HA-SLC45A2 in TYRP1-
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containing structures, and 89.17 ± 1.32% of TYRP1 in HA-SLC45A2-containing 
structures; Figure 4a, e), and the fluorescence signal intensity within positive 
compartments was highly correlated (Figure 4c). By contrast, although TYRP1 and 
OCA2 each primarily localize to subsets of pigment granules (Raposo et al., 2001; 
Sitaram et al, 2012; Sitaram et al., 2009; Vijayasaradhi et al, 1991; Vijayasaradhi et al., 
1995), they label only partially overlapping populations (58.57 ± 4.87% of HA-OCA2 in 
TYRP1-containing compartments, and 48.66 ± 5.32% of TYRP1 in OCA2-containing 
compartments; Figure 4b, e). Moreover, within those overlapping compartments, the 
fluorescence signal intensities of HA-OCA2 and TYRP1 over background correlated 
substantially less well than those of HA-SLC45A2 and TYRP1 (Figure 4d). These data 
suggest that OCA2 and SLC45A2 are enriched in melanosomes of distinct maturation 
stages, with SLC45A2 present in largely the same subset of mature melanosomes as 
TYRP1, while OCA2  occupies a partially different subset of melanosomes. 
The distinct localization patterns for OCA2 and SLC45A2 suggest that they might 
regulate the lumenal pH and pigmentation of melanosomes at different maturation 
stages. We therefore tested for potential differences in melanosome pigmentation in 
melan-uw cells and immortalized melan-p1 melanocytes from OCA2-deficient pink-eyed 
dilute mice. Electron microscopy can be used to define four stages of melanosome 
maturation based on morphology and content of melanin pigments (Seiji et al., 1963). 
Stages I and II lack pigment, but are distinguished by the presence of disorganized 
intralumenal fibers (stage I) or well-organized fibrils in parallel intralumenal sheets 
(stage II). Stage III is defined by the appearance of pigment on the fibrils and stage IV 
by pigment throughout the organelle. Electron microscopy analyses showed that relative 
to either WT melan-Ink4a or "rescued" melan-uw cells stably expressing HA-SLC45A2 
(melan-uw:HA-SLC45A2), both melan-uw and melan-p1 cells harbored melanosomes of 
similar size and number, but with more stage III melanosomes and fewer stage IV 
melanosomes (Figure 5a-e). However, only melan-p1 cells contained significantly more 
stage I/II melanosomes than the controls (Figure 5e). Moreover, although we could not 
quantify it, the amount of pigment on the fibrils in stage III melanosomes in melan-p1 
cells consistently appeared to be lower than in melan-uw cells (Figure 5, panels b vs. 
c). Accordingly, quantitative melanin content assays showed that while both melan-uw 
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and melan-p1 had dramatically lower melanin content than melan-Ink4a or melan-
uw:HA-SLC45A2 cells, the melanin content of melan-p1 cells was significantly lower 
than that of melan-uw (Figure 5f). These data indicate that loss of SLC45A2 results in a 
milder phenotype than loss of OCA2. Taken together with the data showing that 
SLC45A2 and OCA2 are found on different subsets of melanosomes (Figure 4), the 
most likely scenario is that OCA2 is required at an earlier stage of melanization than 
SLC45A2 during melanosome maturation. 
 
OCA2 overexpression partially compensates for loss of SLC45A2 expression. 
Given that both OCA2 and SLC45A2 are capable of raising lysosomal pH when 
expressed in HeLa cells, we tested whether overexpression of either protein could 
compensate for the loss of the other. HA-SLC45A2, HA-OCA2, or HA-SLC35D3 as a 
negative control (see Figure 1) were transiently expressed by transfection in either 
Slc45a2-deficient melan-uw melanocytes or Oca2-deficient melan-p1 melanocytes, and 
the fraction of HA-positive cells that were pigmented after 3 days was quantified. As 
expected, very few melan-uw cells expressing HA-SLC35D3 were pigmented above 
background (19.88 ± 5.76%) whereas most HA-SLC45A2 expressing cells were 
pigmented (70.7 ± 5.85%; Figure 6a, b, g). Surprisingly, a large fraction of HA-OCA2-
expressing melan-uw cells were also pigmented (46.37 ± 6.29%; Figure 6c, g), 
suggesting that OCA2 overexpression can compensate for the loss of SLC45A2. By 
contrast, whereas HA-OCA2 expression restored pigmentation to melan-p1 cells (93.17 
± 4.97%), HA-SLC45A2 expression was as ineffective at restoring pigmentation as the 
negative control HA-SLC35D3 (Figure 6d-f, h). Thus, overexpression of SLC45A2 
cannot compensate for the loss of OCA2. These data are consistent with a model in 
which sequential function of OCA2 and then SLC45A2 is required to modulate and 
maintain a nearly-neutral pH in melanosomes. 
 
The light skin-associated SLC45A2-F374 variant protein is expressed at lower 
levels than the dark skin-associated SLC45A2-L374 variant. The major human 
SLC45A2 allele associated with light skin tone encodes a phenylalanine (F) instead of a 
leucine (L) at amino acid position 374, within the eighth transmembrane domain of the 
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predicted 12-transmembrane domain-containing protein (Figure 7a). How does this 
single amino acid substitution impact pigmentation? We reasoned that the F374 variant 
could affect either protein folding/stability, localization to melanosomes, or transporter 
function within melanosomes. To begin to distinguish between these possibilities, we 
generated stable melan-uw cells expressing the HA-tagged dark skin-associated L374 
variant (as used in Figures 1-6), the HA-tagged F374 variant, or HA-SLC35D3 as a 
control (CTRL). Bright field microscopy analysis revealed that cells expressing HA-
SLC45A2-F374 were darker than control cells but lighter than cells expressing HA-
SLC45A2-L374 (Figure 7b), consistent with published results (Cook et al, 2009). The 
observed phenotype was confirmed by quantitative melanin content assay, in which 
cells expressing HA-SLC45A2-F374 harbored significantly more pigment than control 
cells but less than cells expressing HA-SLC45A2-L374 (Figure 7c). The lower level of 
pigmentation in cells expressing HA-SLC45A2-F374 did not reflect reduced SLC45A2 
mRNA expression, as quantitative RT-PCR analyses showed that melan-uw cells 
expressing HA-SLC45A2-F374 had 1.25-fold more SLC45A2 mRNA than the wild-type 
HA-SLC45A2-L374-expressing cells (Figure 7d). However, immunoblotting analyses of 
cell lysates for the HA-tagged proteins revealed that the HA-SLC45A2-L374 stable cell 
line expressed two-fold more HA-SLC45A2 than cells stably expressing the HA-
SLC45A2-F374 variant (Figure 7e, f). These data indicate that the reduced 
pigmentation conferred by the F374 variant is reflected by a post-translational reduction 
in SLC45A2 protein content.  
To test whether the reduced protein content of the F374 variant reflected increased 
protein degradation, we assessed the protein stability of each variant over time in stably 
transduced melan-uw cells. Cells were treated with cycloheximide (CHX) to block new 
protein synthesis, and the amount of HA-SLC45A2 remaining in cell lysates at different 
time points was assessed by immunoblotting. While the levels of both variants were 
substantially reduced by 32 h following CHX treatment, HA-SLC45A2-F374 was 
degraded at a higher rate than HA-SLC45A2-L374 (L374 half-life, 53.2 h; F374 half-life, 
8.5 h) and was nearly completely eliminated by 32 h (Figure 8a, c). To determine 
whether the rapid decline in the HA-SLC45A2-F374 variant protein levels were 
dependent on proteasomal degradation, cells were treated with the proteasome inhibitor 
 13 
MG132 during the CHX chase. MG132 treatment nearly completely blocked the gradual 
disappearance of HA-SLC45A2-L374, and also blocked the rapid degradation of HA-
SLC45A2-F374 at early chase times (Figure 8b, c). MG132 treatment did not, however, 
block the slow degradation of HA-SLC45A2-F374 at later time points (Figure 8b, c). 
These data indicate that normal turnover of L374 and of the labile fraction of F374 
requires proteasome activity, but that rapid degradation of F374 occurs by a 
proteasome-independent mechanism. To test for the role of endolysosomal 
degradation, cells were treated with the vacuolar ATPase inhibitor bafilomycin A1 
(BafA1) during the CHX chase. BafA1 treatment caused significant cell death by 24 h, 
but within the first 16 h blocked degradation of both HA-SLC45A2-L374 and -F374, 
suggesting that degradation was largely mediated in endolysosomes (Figure EV2). 
Importantly, dIFM analysis showed that HA-SLC45A2-F374 colocalized with TYRP1 to a 
similar extent as HA-SLC45A2-L374 (Figure 8d, e), indicating that the cohort of non-
degraded HA-SLC45A2-F374 variant localizes properly to melanosomes where it 
retains some function in supporting elevated pH.   
Taken together, these data suggest that the light skin-associated SLC45A2-F374 
variant is less stable than the dark skin-associated SLC45A2-L374 variant due to 
endolysosomal proteolysis that is proteasome-dependent, resulting in lower SLC45A2 
activity in melanosomes. 
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DISCUSSION 
SLC45A2 is a critical determinant of skin and eye pigmentation, but until now its 
localization and functional role in melanogenesis have not been clearly delineated. 
Using a functional epitope-tagged form of SLC45A2 expressed in immortalized 
SLC45A2-deficient epidermal mouse melanocytes, we show here that SLC45A2 
localizes to a subset of mature melanosomes marked by TYR and TYRP1 expression, 
where it partially accumulates in subdomains of the organelle outer membrane. When 
expressed ectopically in HeLa cells, SLC45A2 localizes to subdomains of the lysosomal 
membrane and functions to increase lysosomal pH, supporting a previously proposed 
role in neutralizing melanosomes (Bin et al., 2015). Although the melanosomal chloride 
channel OCA2 also functions to neutralize melanosome pH (Bellono et al., 2014), 
SLC45A2 localizes to a partially distinct cohort of melanosomes, and SLC45A2-deficient 
melanocytes harbor melanosomes that are more pigmented than OCA2-deficient cells – 
together suggesting that SLC45A2 functions at a later melanosome maturation stage 
than OCA2. Accordingly, overexpression of OCA2 in SLC45A2-deficient melanocytes 
compensated for SLC45A2 deficiency in pigment production, whereas SLC45A2 
overexpression could not compensate for OCA2 deficiency. Although it is possible that 
these data reflect the distinct abilities of the OCA2 channel and the SLC45A2 
transporter to modulate pH on the same melanosome subsets, the localization of these 
two proteins to partially distinct subsets lead us to conclude that SLC45A2 functions to 
neutralize lumenal pH at a later stage of melanosome maturation than OCA2. We also 
identified the mechanism underlying the pigmentation phenotype of the light skin-
associated F374 variant of SLC45A2. Although SLC45A2-F374 localizes to 
melanosomes like the dark skin-associated L374 variant, SLC45A2-F374 is less stable 
and more rapidly degraded than -L374, resulting in reduced SLC45A2-F374 protein 
levels at steady state. Together, our data (1) indicate that SLC45A2 regulates 
melanogenesis by controlling melanosome pH in a manner that is non-redundant with 
OCA2 and (2) uncover the mechanism by which a common genetic variant imparts light 
skin color.   
 15 
Our data indicate that SLC45A2 localizes to the melanosomal membrane, where we 
propose that it directly functions to increase lumenal pH. This is analogous to other 
proteins on the melanosome membrane, such as the chloride channel OCA2 and the 
cation channel TPC2, which also directly regulate melanosome pH through ion transport 
(Ambrosio et al., 2016; Bellono et al., 2014; Bellono et al., 2016; Sitaram et al., 2009), 
and contrasts with ion transporters/channels that may indirectly regulate melanosome 
pH through effects on other organelles. For example, the putative solute transporter 
MFSD12 negatively regulates pigmentation from lysosomes (Crawford et al., 2017) and 
NCKX5 encoded by SLC24A5, the gene deficient in OCA6, appears to positively 
regulate pigmentation from the trans Golgi network (Ginger et al, 2008; Rogasevskaia et 
al, 2019). Together, these observations suggest that melanosome pH is regulated both 
directly and indirectly via a complex network of putative channels/transporters. Further 
work is necessary to identify other regulators of melanosome pH and to understand how 
these proteins cooperate to fine-tune the lumenal pH of melanosomes, thereby 
controlling melanin synthesis. 
When expressed at the plasma membrane in yeast, SLC45A2 functions as a 
sucrose/proton symporter that transports sucrose from the extracellular space into the 
cytosol in a manner that requires a proton gradient and is maximal at a slightly acidic pH 
(Bartölke et al., 2014). Interestingly, SLC45A2 and other SLC45 family members can 
transport not only the disaccharide sucrose but also the monosaccharides glucose, 
fructose, and mannose (Bartölke et al., 2014). If it were to function similarly in 
melanocytes, SLC45A2 would expel protons and sugar molecules from the 
melanosome lumen into the cytosol, hence increasing melanosome pH.  Whether 
sugars are substrates for SLC45A2 under physiological conditions in melanosomes 
remains to be determined, but given that lysosomal enzymes are present within 
maturing melanosomes (Diment et al, 1995; Raposo et al., 2001), it is possible that 
monosaccharides released from glycoproteins by lysosomal glycosidases in early stage 
melanosomes could serve as substrates for sugar/proton symporter activity. Our data 
show that expression of SLC45A2 in lysosomes of HeLa cells is sufficient to increase 
pH, indicating that its proton-dependent symporter activity is sufficient to raise lumenal 
pH by counteracting the activity of the vacuolar ATPase (vATPase), which pumps 
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protons into the lumen of both melanosomes and lysosomes in an ATP-dependent 
manner (Bhatnagar & Ramalah, 1998; Mindell, 2012; Tabata et al, 2008). Sugar co-
transport from the melanosome into the cytosol would also decrease the osmotic 
concentration inside the melanosome, requiring counter-ion transport to balance solute 
concentrations. Further investigation into the melanosomal channels, transporters, and 
exchangers is required to understand how the melanosome regulates not only its pH but 
also its osmolarity. 
Unlike melanosomal proteins such as TYRP1 that are detected relatively uniformly on 
the melanosome membrane by IFM, SLC45A2 is sometimes detected in a punctate 
pattern, corresponding to specific subdomains of the melanosome membrane. The 
nature of these subdomains and the mechanism by which SLC45A2 assembles into 
them remains unclear. The punctate localization is conserved on lysosomes upon 
ectopic expression of SLC45A2 in non-pigmented HeLa cells, suggesting that the 
assembly of SLC45A2 into subdomains does not require interactions with melanocyte-
specific proteins. Some cells expressing HA-SLC45A2 displayed a mixture of punctate 
and ring-like SLC45A2 patterns on melanosomes. This might either reflect an artifact of 
overexpression or the consequence of a regulated process of aggregate assembly that 
may be influenced by melanosome contents or other features of melanosome 
maturation. The composition, regulation and function of these SLC45A2-containing 
structures warrants further investigation. 
The high colocalization between SLC45A2 and TYRP1 suggests that SLC45A2 is co-
delivered with TYRP1 to maturing melanosomes, likely via BLOC-1-dependent 
membrane transport (Setty et al, 2008; Setty et al, 2007). In contrast, despite similar 
requirements for BLOC-1 for delivery to melanosomes (Sitaram et al., 2012), there is 
significantly less overlap between OCA2 and TYRP1, and in structures in which they 
overlap their abundance is inversely related. Moreover, the relative melanin content of 
SLC45A2- and OCA2-deficient melanocytes is different, such that SLC45A2-deficient 
melanocytes harbor more mature melanosomes and slightly higher pigmentation than 
OCA2-deficient melanocytes. While these latter data alone could be interpreted to 
reflect distinct activities of OCA2 and SLC45A2 in facilitating increased melanosomal 
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pH, together with the localization data they suggest that OCA2 functions at an earlier 
melanosomal maturation stage compared to SLC45A2. This would imply either that the 
melanosome delivery of OCA2 and TYRP1/SLC45A2 is staggered or that OCA2 is 
cleared soon after delivery. The latter is supported by the short half-life of OCA2 
(Sitaram et al., 2009), the dependence of this half-life on melanization (Donatien & 
Orlow, 1995), and the accumulation of OCA2 on internal membranes in mature 
melanosomes (Sitaram et al., 2012). Based on these observations, we propose a model 
in which OCA2, SLC45A2, and TYRP1 are delivered together to maturing melanosomes 
– which harbor active vATPase to acidify their lumen (Bhatnagar & Ramalah, 1998; 
Tabata et al., 2008). OCA2 would facilitate a rapid efflux of chloride ions, immediately 
reducing membrane potential and thereby slowing vATPase activity. As the 
melanosomes mature, OCA2 clearance from the limiting membrane coupled with 
continued SLC45A2 arrival would support a slow but continued melanosome 
neutralization mediated by SLC45A2 proton export, counteracting residual vATPase 
activity. If this model were true, then OCA2 overexpression, by prolonging exposure on 
the melanosomal membrane, would antagonize vATPase activity in a more sustained 
way, perhaps resulting in slow proton efflux from the melanosome through another 
means such as membrane recycling (Dennis et al, 2016). This model would thus explain 
our observation that OCA2 overexpression can compensate for SLC45A2 loss but that 
SLC45A2 overexpression – with its limited capacity for proton export – cannot 
compensate for OCA2 loss.   
The SLC45A2-F374 variant is the predominant allele in Northern Europe and is strongly 
associated with light skin and hair and blue eyes (Branicki et al., 2008; Cook et al., 
2009; Lao et al, 2007; Lopez et al., 2014; Lucotte et al, 2010; Lucotte & Yuasa, 2013; 
Mukherjee et al, 2013; Sabeti et al, 2007; Soejima & Koda, 2007; Soejima et al, 2006; 
Yuasa et al., 2006). However, the mechanism responsible for the reduced pigmentation 
associated with SLC45A2-F374 was previously unclear. We show here that compared 
to SLC45A2-L374, expression of SLC45A2-F374 in SLC45A2-deficient melanocytes 
results in a more meager increase in pigmentation, despite higher levels of SLC45A2 
mRNA. Our results demonstrate that this is due to instability of the SLC45A2-F374 
protein, leading to a higher rate of degradation relative to SLC45A2-L374 through a 
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proteasome- and vATPase-dependent mechanism. Nevertheless, the remaining cohort 
of SLC45A2-F374 localizes appropriately to melanosomes. Thus, we propose that the 
reduced pigmentation associated with the F374 allele is due to insufficient levels of 
SLC45A2-F374 on the melanosomal membrane to maintain optimal neutral pH for 
maximal TYR activity, thus resulting in decreased melanin synthesis. Whether 
SLC45A2-F374 is rapidly degraded following melanosomal delivery or is missorted for 
endolysosomal degradation remains to be determined.    
In conclusion, our data significantly advance our understanding of SLC45A2 and its 
function on melanosomes and begin to unravel the stepwise contributions of SLC45A2 
and OCA2 to lumenal pH regulation and proper melanosome maturation. We also 
reveal the molecular basis explaining why the SLC45A2-F374 variant is a hypomorphic 
allele and propose a mechanism by which this allele contributes to lighter pigmentation 
in humans. The regulation of melanosome pH through the coordinated function of 
transporters, channels, and other proteins requires further investigation.  
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MATERIALS AND METHODS 
 
Reagents 
 
Unless otherwise specified, chemicals were obtained from Sigma-Aldrich (St. Louis, 
MO) and tissue culture reagents from Life Technologies/Thermo Fisher Scientific 
(Waltham, MA). Protease inhibitors were purchased from Roche Diagnostics (Rotkreuz, 
Switzerland), gene amplification primers from Integrated DNA Technologies (Coralville, 
IA), GoTaq DNA polymerase from Promega Corp. (Madison, WI), and restriction 
enzymes and T4 DNA ligase from New England Biolabs (Ipswich, MA).  
 
Cell culture 
 
Immortalized melanocyte cell lines melan-p1 (OCA2 deficient) from C3H-Oca2cp/25H 
(pink-eyed dilute) mice (Sviderskaya et al, 1997), and "wild-type" (WT) melan-Ink4a-
Arf1 (formerly called melan-Ink4a-1; referred to here as melan-Ink4a or WT) from 
C57BL/6J-Ink4a-Arf−/− (Cdkn2 null) mice (Sviderskaya et al., 2002) have been described 
and were derived from the skins of neonatal mice. Three immortal SLC45A2 deficient 
melanocyte lines, melan-uw-1, -2 and -3, were similarly derived from the skins of 
neonatal C57BL/6J- Ink4a-Arf-/- Slc45a2uw/uw (underwhite) mice. Mice were housed and 
interbred by Dr Lynn Lamoreux (Texas A&M University, College Station, TX, USA), and 
skins were shipped on ice to London.  Only the melan-uw-2 line (referred to here as 
melan-uw) was used here because they were more uniform in pigmentation both before 
and after stable expression of HA-SLC45A2. All cells were cultured at 37˚C and 10% 
CO2 in RPMI 1640 medium supplemented with 10% FBS (Atlanta Biologicals) and 200 
nM 12-O-tetradecanoylphorbol-13-acetate (TPA). Melan-uw cells grow poorly in the 
absence of adenylate cyclase activators, which also stimulate the transcription of 
melanogenic genes. In order to properly compare them, melan-uw cells, melan-p1 cells, 
and all stable cell lines derived from these cells were additionally supplemented with 
200 pM cholera toxin. Melan-Ink4a cell medium was not supplemented with cholera 
toxin, but we expect that this might contribute to underestimating the differences 
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between Melan-Ink4a and the other cell lines due to the increased expression of 
melanogenic genes in the latter. Cell lines were authenticated by restoration of 
pigmentation upon expression of the wild-type form of their defective genes, and verified 
to be negative for mycoplasma every 2-3 months using the MycoAlert Mycoplasma 
Detection Kit (Lonza). 
 
Retrovirus production from transiently transfected Plat-E cells(Morita et al, 2000) and 
retroviral transduction of melanocyte cell lines were carried out as described previously 
(Meng et al, 2012; Setty et al., 2007). Briefly, Plat-E cells were transfected with retroviral 
DNA constructs using Lipofectamine 2000 (Thermo Fisher), and the medium was 
replaced the next day. Retrovirus-containing supernatants were collected 48 h later, 
filtered, and added to melan-Ink4a cells or melan-uw cells in a 1:1 ratio with fresh 
medium. The medium was replaced the next day, and pools of stable transductants 
were selected 24 h later by adding 300 μg/ml hygromycin B to the medium. Stable 
transfectants were occasionally treated with 200 µg/ml hygromycin B for 2–3 d to 
maintain selective pressure for the transgene. For transient transfections, cells on glass 
coverslips were transfected with DNA constructs using Lipofectamine 3000 or 
Lipofectamine 2000 (Thermo Fisher), and the medium was replaced the next day. Cells 
were fixed using 4% formaldehyde/PBS 48 or 72 hours after transfection and stored at 
4°C for immunolabeling and analysis.  
 
DNA Constructs 
 
We first generated a GFP-SLC45A2 (L374) fusion protein by inserting human SLC45A2 
cDNA, generated by RT-PCR of RNA isolated from darkly pigmented human epidermal 
melanocytes, into the BamHI/Xhol sites of pcDNA4/TO (Invitrogen/Life Technologies) in 
frame with GFP and a Gly-Ala-Gly-Ala linker previously inserted in the AflII/HindIII sites 
(sequence available upon request). To generate HA-tagged SLC45A2, the insert from 
pcDNA4/TO-GFP-SLC45A2 was amplified by PCR adding XhoI and NotI restriction 
sites at the 5' and 3' ends, respectively, and subcloned into the respective sites of pCI 
(Promega). An N-terminal Kozak consensus start site, HA tag, and Gly-Ser linker were 
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subsequently added by PCR using a distinct forward primer (5’-
gcatatctcgagatgTACCCATACGATGTTCCAGATTACGCTggctcagg 
atctgggatgggtagcaacagtgggc-3’) and the same reverse primer. The HA-SLC45A2 insert 
was subsequently subcloned as a XhoI-NotI fragment into pBMN-(XN)-IRES-hygro to 
generate the retroviral vector encoding HA-SLC45A2. The F374 variant was made by 
site-directed mutagenesis of the pBMN-(XN)-IRES-hygro-HA-SLC45A2 (L374) construct 
using the Clontech site-directed mutagenesis kit. All recombinant plasmids were verified 
by sequencing by the University of Pennsylvania Cell Center, the Nucleic Acid/Protein 
Research Core Facility at the Children's Hospital of Pennsylvania, or Macrogen. 
 
The plasmid-based expression vector pCR3-OCA2-WT-HA-UTR2 and corresponding 
retroviral vector pBMN-OCA2-WT-HA-UTR2 encoding human OCA2 with an exofacial 
HA epitope were described in (Sitaram et al., 2009); pCDM8.1-HA-SLC35D3 encoding 
human SLC35D3 with an N-terminal HA epitope tag was described in (Meng et al., 
2012); and human LAMP1-mCherry in pCDNA3.1 was a generous gift from Sergio 
Grinstein (Univ. of Toronto and Hospital for Sick Children, Toronto, ON, Canada). 
 
Melanin Content Quantification 
 
Melanin quantification by spectroscopy was done essentially as described (Delevoye et 
al, 2009). Briefly, melanocytes seeded on 6-cm dishes were trypsinized, pelleted, and 
sonicated in melanin buffer (50 mM Tris, 2 mM EDTA, and 150 mM NaCl, pH 7.4) 
supplemented with protease inhibitor cocktail (Roche). Insoluble material was pelleted 
for 15 min at 16,000 g (4°C), rinsed in ethanol/diethyl ether (1:1), and dissolved in 2 M 
NaOH/20% DMSO at 60°C. The optical density at 492 nm was measured to estimate 
melanin content and normalized to protein concentration as determined by BCA protein 
determination kit (Thermo Fisher). Plat-E cells, an unpigmented cell line, were used as 
a negative control. Statistical significance from at least 3 independent experiments was 
determined by Welch’s ANOVA with Dunnett T3 test for multiple comparisons. 
 
Antibodies 
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Primary antibodies used and their sources (listed in parentheses) include: mouse 
monoclonal antibody TA99/Mel5 to TYRP1 (American Type Culture Collection; 
Rockville, MD); rat monoclonal antibody 3F10 to the HA11 epitope (Sigma); mouse 
monoclonal antibody 16B12 to the HA11 epitope (Biolegend); mouse monoclonal 
antibody H4A3 to human LAMP1 (Developmental Studies Hybridoma Bank, Iowa City, 
IA); rabbit anti-LAMP2 (Abcam; for mouse melanocytes); rabbit anti-TYR (Pep7h, to the 
C-terminal 17 amino acids of human TYR (Calvo et al., 1999)); mouse monoclonal 
antibody to γ-Tubulin (Sigma); and rabbit antibody to vinculin (E1E9V; Cell Signaling). 
Species- and/or mouse isotype–specific secondary antibodies from donkey or goat and 
conjugated to Alexa Fluor 488 or Alexa Fluor 594 used in IFM or conjugated to Alexa 
Fluor 680 or Alexa Fluor 790 for immunoblots were obtained from Jackson 
ImmunoResearch Laboratories (West Grove, PA). 
 
Bright field microscopy, immunofluorescence microscopy (IFM), and 
colocalization analyses 
 
IFM analyses of fixed cells were done essentially as described (Dennis et al., 2016). 
Briefly, cells were plated on Matrigel (BD)-coated coverslips, fixed with 4% 
formaldehyde (VWR) in PBS, labeled with primary and secondary antibodies diluted in 
PBS/0.02% saponin/0.01% BSA, mounted onto slides using Prolong Gold 
(ThermoFisher), and analyzed on a Leica DMI-6000 microscope equipped with a 40× or 
63× objective lens (Leica; 1.4 NA), a Hamamatsu Photonics ORCA-Flash4.0 sCMOS 
C11440-22CU digital camera, and Leica Application Suite X (LAS X) software. Images 
in sequential z planes (0.2 µm step size) were deconvolved with Microvolution software 
and further analyzed using ImageJ (http://fiji.sc/Fiji; National Institutes of Health). 
 
Because SLC45A2 localized partially to subdomains on the melanosome membrane 
and thus did not fully overlap other melanosomal markers, previously used automated 
methods to quantify colocalization did not yield meaningful values; similarly, OCA2 
localized largely to the interior of melanosomes(Sitaram et al., 2012; Sitaram et al., 
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2009) and was thus partially distinct from the distribution of TYRP1 or TYR cytoplasmic 
domain on the melanosome membrane. Therefore, quantification of the degree of 
overlap between two channels on individual organelles was performed manually on 
deconvolved, Z-projected images of cells in ImageJ. In brief, single-channel images and 
a merged image were synchronized using “Analyze > Tools > Synchronize Windows;” 
signals that were localized to the same organelle were counted using the “Multi-Point” 
tool; remaining signal in single channels were counted using the “Multi-Point” tool; and 
the total colocalized structures was calculated as a percentage of total structures for 
each channel. Statistical significance was determined using one-way ANOVA with 
Tukey’s multiple comparisons test, Welch’s ANOVA with Dunnett T3 post hoc test, or 
Kruskal-Wallis test with Dunn’s multiple comparisons test where appropriate.  
 
Scoring of pigmentation in transfected melan-uw and melan-p1 cells was done blinded. 
Fixed, stained coverslips were randomly assigned numbers and samples were revealed 
only after images were taken and scored. Statistical significance was determined using 
one-way ANOVA with Holm-Sidak’s test for multiple comparisons. 
 
Fluorescence intensity analyses 
 
Object-based fluorescence intensity was measured using ImageJ as described in 
https://www.unige.ch/medecine/bioimaging/files/1914/1208/6000/Quantification.pdf. 
Briefly, 8-bit, single-channel images were opened in ImageJ and brightness and 
contrast adjusted for each image. The image was duplicated and a threshold applied 
using “Image > Adjust > Auto Local Threshold.” To multiply binary images of the two 
channels of interest, we used “Process > Image Calculator > Multiply.” To redirect 
intensity measurements from binary image to fluorescent image, we used “Analyze > 
Set measurements” and pulled down the “Redirect to:” menu to choose the appropriate 
fluorescent image, making sure “Area” and “Integrated density” were also checked. With 
"binary image" clicked, we used “Analyze > Analyze Particles” to measure object 
intensity. This was repeated for each channel, and for each sample values were 
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normalized to the highest integrated density value in each channel. At least 10 cells 
from each of two independent experiments were analyzed. 
 
Lysosomal pH measurements 
 
HeLa cells were transfected one day prior to imaging experiments with LAMP1-mCherry 
alone, mCherry-OCA2 alone, or HA-SLC45A2 and LAMP1-mCherry to identify 
endolysosomes, and incubated with 1 μM LysoSensor-ND160 (Thermo Fisher) for 5 
min. Lysosensor was excited at 405 nm and its emission detected at 417-483 nm (W1) 
and 490-540 nm (W2). The ratio of LysoSensor W1/W2 emission in endolysosomes 
expressing LAMP1-mCherry was assigned a pH value based on a calibration curve 
generated prior to each experiment using solutions containing 125 mM KCl, 25 mM 
NaCl, 24 μM Monensin, and varying concentrations of MES to adjust the pH to 3.5, 4.5, 
5, 5.5, 6.5, 7, 7.5. The fluorescence ratio was linear from pH 5 - 7.0. Statistical 
significance was determined by Welch’s ANOVA with Games-Howell post hoc test for 
multiple comparisons. 
 
Electron microscopy 
 
Melanocytes were cultured in 10-cm dishes and fixed in situ with Karnovsky's fixative 
[4% paraformaldehyde (VWR Scientific, Radnor, PA), 4 mM calcium chloride, 72 
mM sodium cacodylate, pH 7.4] containing 0.5% glutaraldehyde (Polysciences, 
Warrington, PA) for 1–2 h at room temperature. This solution was then removed and 
replaced with Karnovsky's fixative containing 2% glutaraldehyde, and the cells were 
fixed overnight at room temperature. Cells were collected by scraping using a cell 
scraper and centrifugation at 27 g for 5 min, resuspended in Karnovsky's fixative 
containing 0.5% glutaraldehyde, and stored at 4°C until processing. After subsequent 
buffer washes, the samples were post-fixed in 2.0% osmium tetroxide with 1.5% 
K3Fe(CN)6 for 1 hour at room temperature, and then rinsed in deonized water prior to en 
bloc staining with 2% uranyl acetate. After dehydration through a graded ethanol series, 
the tissue was infiltrated and embedded in EMbed-812 (Electron Microscopy Sciences, 
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Fort Washington, PA) ) at the Electron Microscopy Resource Laboratory (University of 
Pennsylvania). Thin sections were stained with uranyl acetate and SATO lead and 
examined with a JEOL 1010 electron microscope fitted with a Hamamatsu digital 
camera (Hamamatsu, Bridgewater, NJ) and AMT Advantage NanoSprint500 software 
(Advanced Microscopy Techniques, Woburn, MA). 
 
For melanosome staging, a combined total of at least 20 cells from at least two 
independent experiments and over 600 melanosomes were analyzed for each cell type 
and the analysis was done blinded. The number of stage I/II, stage III, and stage IV 
melanosomes were quantified, and the percentage of melanosomes at each stage was 
calculated for each cell. These data were analyzed and plotted using Prism 6 
(GraphPad, La Jolla, CA), and statistical significance was determined by Welch’s 
ANOVA with multiple comparisons (samples compared to melan-Ink4a) and Dunnett T3 
test for multiple comparisons. 
 
Immunoblotting 
 
Melan-uw cells stably expressing HA-SLC45A2-L374, HA-SLC45A2-F374, or HA-
SLC35D3 cultured in 60 mm Petri dishes were treated with 25 µg/ml cycloheximide ± 25 
µM MG-132 or ± 25 nM bafilomycin A1 and collected for immunoblot every 8 h for 32 h. 
For each time point the cells were rinsed in cold PBS before pelleting by centrifugation. 
After collection of all time points, cell pellets were  resuspended in 1X Laemmli buffer 
(Laemmli, 1970), lysed by sonication, and heated at 37°C for 5 minutes. Protein 
concentration for each sample was measured using the BCA assay (Pierce) according 
to the manufacturer's protocol. 20 µg protein from each sample was fractionated by 
SDS-PAGE on 10% polyacrylamide gels, and transferred to PVDF membranes 
(Immobilon-FL, Millipore). Membranes were blocked with 5% milk in TBS, incubated 
overnight with antibodies to HA or vinculin diluted in TBS/0.5% Tween, washed with 
TBS/0.5% Tween, and analyzed using Alexa Fluor 680 or 790-conjugated secondary 
antibodies and Odyssey imaging system (LI-COR, Lincoln, NE). For immunoblotting 
without drug treatments, the method was the same except that cycloheximide,  MG-132, 
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and bafilomcin A1 were not added and antibodies to tubulin were used for the loading 
control. Statistical significance was determined using one-way ANOVA with Dunnett’s 
test for multiple comparisons. Protein half-lives were calculated using one phase decay. 
 
Quantitative RT-PCR 
 
Total RNA was extracted from melan-uw cells stably expressing either HA-SLC45A2, 
HA-SLC45A2-F374 or HA- SLC35D3 as a control using the RNeasy Plus Kit (Qiagen), 
and 3 µg was reverse transcribed (RT) using the SuperScript III kit (Life Technologies). 
The resulting cDNA was used for qPCR. Primers were designed using Primer3 
(http://bioinfo.ut.ee/primer3-0.4.0/) to span an exon-exon junction to avoid amplification 
of any contaminating genomic DNA, and were as follows: SLC45A2 (NM_016180.3) - F: 
CCCTGTACACTGTGCCCTTT and R: CTTCCCTCTCACGCTGTTGT. Reactions were 
prepared according to the manufacturer’s protocol using SYBR Select Master Mix 
(Invitrogen/ThermoFisher Scientific) and cycled on a Real-Time PCR System (Biorad).  
β-actin was used as an internal control and all reactions were run in triplicate. mRNA 
levels were quantified by calculating average 2-∆∆Ct values, where Ct is the cycle 
number for the control and target transcript at the chosen threshold. ∆Ct = Cttarget - Ctβ-
actin was calculated by subtracting the average Ct of β-actin from the average Ct of the 
target transcript. The ∆Ctmean was calculated for the reference sample (L374) and ∆∆Ct 
= ∆Ct - ∆Ctmean was calculated by subtracting the ∆Ctmean from the ∆Ct. The relative 
mRNA expression of samples compared to L374 samples was calculated by 2-∆∆Ct. 
Statistical significance was determined using Welch’s ANOVA with Dunnett T3 test for 
multiple comparisons. 
 
Statistical Analyses 
 
Except where noted, we performed each experiment three times and sample sizes are 
as indicated in each figure legend. Statistical data are presented as mean ± SEM. 
Statistics were calculated in GraphPad Prism using ordinary unpaired Student’s t test, 
ordinary one-way ANOVA, Welsh’s ANOVA, or Kruskal-Wallis test with post hoc 
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correction as specified. Welsh’s ANOVA or Kruskal-Wallis tests were used instead of 
ordinary one-way ANOVA when the data displayed heteroscedasticity or did not display 
a normal distribution, respectively, which were determined using Graphpad Prism. 
Significant differences between control or experimental samples are indicated (****, p < 
0.0001; ***, p < 0.001; **, p < 0.01; *, p < 0.05). Only p < 0.05 was considered as 
statistically significant.
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FIGURE LEGENDS 
 
Figure 1. HA-SLC45A2 functionally restores pigmentation in Slc45a2-deficient 
underwhite melanocytes. Wide field microscopy with bright field illumination of melan-
Ink4a (a) and melan-uw (b) cells to visualize pigmentation. Scale bar, 10 µm. Mouse 
melan-uw cells were transiently transfected with plasmids encoding human SLC45A2 
with an N-terminal HA epitope (HA-SLC45A2) or with a comparably HA-tagged control 
polytopic protein, SLC35D3 (HA-SLC35D3). 48-72 h after transfection, HA-expressing 
cells were scored for their level of pigmentation. c-e, examples of unpigmented (c, like 
untransfected cells), partially pigmented (d) and fully pigmented (e) cells. Scale bar, 
10µm. f, g, quantification of the percentage of HA-expressing cells with partial (gray) or 
full (black) pigmentation at 48 (f) or 72 (g) h after transfection. Note that all cells except 
melan-Ink4a were treated with 200 pM cholera toxin. Data represent mean ± SEM from 
3 independent experiments and the following total sample sizes: 234 (HA-SLC45A2) 
and 109 (HA-SLC35D3) at 48 h, 173 (HA-SLC45A2) and 108 (HA-SLC35D3) at 72 h. 
***, p < 0.001; ****, p<0.0001 by unpaired two-tailed t-test.  
 
Figure 2. HA-SLC45A2 localizes to melanosomes when expressed in SLC45A2-
deficient melan-uw melanocytes.  (a-c) Melan-uw cells stably expressing HA-tagged 
SLC45A2 were fixed, labeled for HA (green) and for TYRP1 (a), TYR (b), or LAMP2 (c) 
(magenta), and analyzed by dIFM and bright field (BF) microscopy to visualize melanin. 
Insets of boxed regions are magnified 7.5 times. Scale bar, 10 µm. SLC45A2 that 
localized to TYRP1- or TYR-labeled compartments (white arrows) or SLC45A2 (cyan 
arrowheads) and LAMP2 (white arrowheads) on separate compartments are indicated. 
(d) The percentage of compartments with both markers in a-c was quantified by manual 
counting of at least 13 cells each from 3 separate experiments. Colocalization is 
represented as mean ± SEM of label 1 vs label 2, in which the number of compartments 
containing both label 1 and label 2 is presented as a percentage of the total number of 
compartments containing label 2. The % colocalization between TYRP1 and LAMP2 
was quantified as a negative control. Data are from 3 independent experiments with the 
following total sample sizes: 13 (TYRP1 vs HA; HA vs TYRP1; LAMP2 vs HA; HA vs 
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TYRP1; TYRP1 vs LAMP2; LAMP2 vs TYRP1) and 17 (TYR vs HA; HA vs TYR; HA vs 
Pigment; Pigment vs HA). Statistical significance was determined using one-way 
ANOVA with Tukey post hoc test for multiple comparisons; only significant differences 
are indicated. *, p < 0.05; **, p < 0.01; ****, p < 0.0001.  
 
Figure 3. HA-SLC45A2 expressed in HeLa cells localizes to lysosomes and 
neutralizes lysosomal pH. A. HeLa cells transiently transfected with HA-SLC45A2 
were fixed, labeled for HA (green) and the lysosomal protein LAMP1 (magenta), and 
analyzed by dIFM. Merged image is at right. Insets of boxes are magnified 5-fold. Scale 
bar, 10 µm. b. HeLa cells transiently transfected with LAMP1-mCherry alone, mCherry-
OCA2, or HA-SLC45A2 and LAMP1-mCherry were incubated with Lysosensor DND-
160, and analyzed by fluorescence microscopy with excitation wavelength 405. The 
W1/W2 emission ratio for mCherry-labeled endolysosomes was calculated and 
compared to that from a standard curve to define pH as described in Materials and 
Methods. Data represent mean ± SEM from 3 independent experiments with the 
following total sample sizes: 319 LAMP1-mCherry+ endolysosomes, 391 OCA2-
mCherry+ endolysosomes, and 299 HA-SLC45A2/LAMP1-mCherry+ endolysosomes.  
Statistical significance was determined using Welch’s ANOVA with Games-Howell test 
for multiple comparisons; only significant differences are indicated. ****, p < 0.0001. 
 
Figure 4. SLC45A2 and OCA2 occupy partially distinct melanosome subsets. (a, 
b) melan-Ink4a cells transiently expressing either HA-SLC45A2 (a) or HA-OCA2 (b) 
were fixed, labelled for HA (green) and TYRP1 (magenta), and analyzed by dIFM and 
bright field microscopy. Insets of boxed regions are magnified 7.5 times. Scale bar, 10 
µm. White arrows, colocalization of HA-SLC45A2 or HA-OCA2 to TYRP1-containing 
compartments at comparable relative intensities; white arrowhead, compartments with 
high HA-OCA2 and low TYRP1; cyan arrowhead, compartments with low HA-OCA2 and 
high TYRP1. (c, d) Quantification of the object-based fluorescence intensity of HA-
SLC45A2 versus TYRP1 (c) or HA-OCA2 versus TYRP1 (d) in 10 cells each from 3 
independent experiments. Correlation coefficients (r2) of fluorescent intensities for each 
pair of markers is indicated.  (e) Manual quantification (mean ± SEM) of the % 
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colocalization between TYRP1 and either HA-SLC45A2 or HA-OCA2 and TYRP1, 
shown as a percentage of total TYRP1-, SLC45A2-, or OCA2-containing compartments. 
Values are presented as label 1 vs label 2, in which compartments containing both label 
1 and label 2 is indicated as a percentage of total compartments containing label 2. 
Data are quantified from 3 independent experiments with the following total sample 
sizes: 13 (HA-SLC45A2) and 14 (HA-OCA2). Statistical significance was determined 
using Welch’s ANOVA with Dunnett T3 test for multiple comparisons; only significant 
differences are indicated. ***, p < 0.001; ****, p < 0.0001. 
 
 
Figure 5. SLC45A2 is required for melanosomes to progress from stage III to 
stage IV. (a-d) melan-Ink4a (a), melan-uw (b), melan-p1 (c), and melan-uw cells stably 
expressing HA-SLC45A2 (melan-uw:HA-SLC45A2; d) were fixed and analyzed by 
conventional transmission electron microscopy. Insets of boxed regions on the left were 
magnified 4.5 times on the right. I/II, stage I/II melanosomes; III, stage III melanosomes; 
IV, stage IV melanosomes. Scale bars, 500 nm (left) and 200 nm (right). (e) The 
number of stage I/II, stage III, and stage IV melanosomes per cell was quantified for 
each of the cell lines and is shown as a percentage of total counted melanosomes per 
cell. For each stage, data represent the mean ± SEM from the following number of 
independent experiments, cells, and melanosomes: melan-Ink4a (2, 54, 717), melan-uw 
(3, 49, 1292), melan-p1 (2, 27, 626), and melan-uw:HA-SLC45A2 (3, 76, 1927). 
Statistical analyses were performed by Welch’s ANOVA with multiple comparisons to 
melan-Ink4a for each stage and Dunnett T3 test for multiple comparisons. (f) Melanin 
content in cell lysates was determined by spectrometry relative to total protein content. 
Plat-E cells are included as a non-pigmented cell control. The data are presented as a 
percentage normalized to melanin content in melan-uw samples ± SEM and represent  
at least 3 independent experiments performed in duplicate or triplicate. Statistical 
significance was determined by Welch’s ANOVA with Dunnett T3 test for multiple 
comparisons. Except where indicated, statistical comparisons were made relative to 
melan-uw. Note that all cells except melan-Ink4a and Plat-E were treated with 200 pM 
cholera toxin. **, p < 0.01; ***, p < 0.001; ****, p < 0.0001; ns, no significant difference. 
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Figure 6. OCA2 overexpression compensates for loss of SLC45A2-dependent 
melanosome neutralization in melanocyte pigmentation. SLC45A2-deficient melan-
uw cells or OCA2-deficient melan-p1 cells were transiently transfected with negative 
control HA-SLC35D3 (a, d), HA-SLC45A2 (b, e), or HA-OCA2 (c, f), and fixed and 
labelled for HA (not shown). Bright field microscopy was used to visualize pigmented 
melanosomes within HA-positive cells. Scale, 10 µm. (g, h) The number of HA-
containing pigmented cells was quantified and is depicted as a mean percentage of total 
HA-containing (HA+) cells ± SEM. Quantification is from the following independent 
experiments and total sample sizes: melan-uw + HA-SLC35D3 (3, 67), melan-uw + HA-
SLC45A2 (9, 320), melan-uw + HA-OCA2 (9, 308), melan-p1 + HA-SLC35D3 (3, 62), 
melan-p1 + HA-SLC45A2 (4, 137), melan-p1 + HA-OCA2 (4, 90). Statistical significance 
was determined using one-way ANOVA with Holm-Sidak’s test for multiple 
comparisons. *, p < 0.05; ***, p < 0.001; ****, p < 0.0001; ns, not significant. 
 
  
Figure 7. The human light skin-associated SLC45A2-F374 variant is expressed in 
melanosomes at lower levels than the dark variant.  (a) Schematic diagram of 
human SLC45A2 primary structure, with transmembrane (gray cylinders), luminal and 
cytosolic domains (gray lines) indicated. An asterisk indicates the position of L/F374. (b) 
Stably transfected melan-uw cells expressing HA-SLC45A2-L374 (left), HA-SLC45A2-
F374 (center), or HA-SLC35D3 as a negative control (right) were imaged by bright field 
microscopy to emphasize pigmentation levels. Bar, 10 µm.  (c-f) Stably transfected 
melan-uw cells expressing HA-SLC45A2-L374, HA-SLC45A2-F374, or HA-SLC35D3 
(CTRL) were analyzed for (c) melanin content by quantitative spectroscopy assay, (d) 
SLC45A2 mRNA expression by quantitative RT-PCR, or (e, f) HA protein expression by 
immunoblotting relative to tubulin as a loading control. A representative immunoblot is 
shown in e; quantification of HA expression normalized to tubulin levels over three 
experiments is shown in f. All values are normalized to 100% for cells expressing HA-
SLC45A2-L374. Each experiment was repeated at least three times. Statistical analyses 
were determined by Welch’s ANOVA with Dunnett T3 test for multiple comparisons (c, 
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d) or one-way ANOVA with Dunnett’s test for multiple comparisons (f).  ns, no significant 
difference; *, p < 0.05; ***, p < 0.001; ****, p < 0.0001. 
 
Figure 8. The F374 variant is less stable than the L374 variant and is degraded by 
a proteasome-independent pathway. (a, b) Melan-uw cells stably expressing either 
HA-SLC45A2-L374 (L374; a, b, top) or -F374 (F374;  a, b, bottom) were cultured with 
cycloheximide (CHX; 25 µg/ml) alone (a) or combined with proteasome inhibitor MG132 
(25 µM; b) for the indicated times (h). At the indicated times, cells were harvested and 
whole cell lysates were fractionated by SDS-PAGE and analyzed by immunoblotting for 
HA and for vinculin as a loading control. Relevant regions of the gels are shown. (c) 
Band intensities for HA-SLC45A2 were quantified over three independent experiments, 
normalized to vinculin band intensities, and presented as a percentage of the signal 
observed at time 0 +/- SEM. (d) Band intensities for HA-SLC45A2 after treatment for 8 h 
with CHX alone or with MG132 or 25 nM Bafilomycin A1 (BafA1; blots are shown in 
Expanded View Figure EV2) were quantified over three independent experiments, 
normalized to vinculin band intensities, and presented as a percentage of the signal for 
each isoform at time 0 ± SEM. Statistical significance of values relative to those at time 
0 was determined using ordinary one-way ANOVA with Dunnett post-hoc test for 
multiple comparisons. Only statistically significant differences are noted. (e, f) Melan-uw 
cells stably expressing either HA-SLC45A2-L374 (e, top) or HA-SLC45A2-F374 (e, 
bottom) were fixed, labeled for HA (green) and TYRP1 (magenta), and analyzed by 
dIFM and by bright field microscopy. Merged HA/TYRP1 image is at right; insets of 
boxed regions are magnified 7.5 times. HA-SLC45A2 and TYRP1 localizing to the same 
compartments are indicated with arrows. Scale, 10 µm. (f) The degree of TYRP1 and 
SLC45A2 localization to the same compartments was quantified manually from 14 cells 
over 2 independent experiments, and is presented as label 1 vs label 2, in which the 
colocalization between label 1 and label 2 is a percentage of total label 2. Quantification 
is from 2 independent experiments with 14 cells counted per sample. Statistical 
significance was determined using Kruskal-Wallis test with Dunn’s post hoc test for 
multiple comparisons. ns, no significant difference; *, p < 0.05. 
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Expanded View Figure EV1. HA-SLC45A2 localizes to melanosomes upon 
transient transfection in WT melanocytes. Transiently transfected WT melan-Ink4a 
cells expressing HA-SLC45A2 were fixed, labeled for HA (green) and either TYRP1 (a-
e, magenta), TYR (f-j, magenta) or LAMP2 (k-o, magenta), and analyzed by dIFM and 
by bright field microscopy. Shown are individual bright field (BF) or labeled panels (a-c, 
f-h, and k-m), merged dIFM images (d, I, n) or merged HA and bright field images (e, j, 
o; bright field is pseudocolored blue); boxed regions are magnified 7.5X in insets. Scale, 
10 µm. 
 
Expanded View Figure EV2. Early phase of rapid SLC45A2-F374 degradation is 
blocked by vATPase inhibition. (a) Melan-uw cells stably expressing either HA-
SLC45A2-L374 (L374; a, left) or -F374 (F374;  a, right) were cultured with 
cycloheximide and the vATPase inhibitor bafilomycin A1 (BafA1; 25 nM) for the 
indicated times (h). Cells were then harvested and whole cell lysates were fractionated 
by SDS-PAGE and analyzed by immunoblotting for HA and for vinculin as a loading 
control. Relevant regions of the gels from a representative experiment are shown. (b) 
Band intensities for HA-SLC45A2 were quantified over three independent experiments, 
normalized to vinculin band intensities, and presented as a percentage of the signal 
observed at time 0 +/- SEM. CHX only samples were the same as those used in the 
quantification in Figure 8c.  










